# Clinical Validation of the AliveCor Kardia 12L and 6L Devices

Study · id `cardio:ct-nct05053243` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05053243](<https://clinicaltrials.gov/study/NCT05053243>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05053243

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.

## Technical summary

Registry record NCT05053243. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-27 (actual); primary completion 2022-02-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 221 participants (enrolled count; ClinicalTrials.gov record NCT05053243, source copy `cardio:ctgov-nct05053243-2024-03-06`, retrieved 2026-10-26)
- Started: 2021-09-27 (actual) (ClinicalTrials.gov record NCT05053243, source copy `cardio:ctgov-nct05053243-2024-03-06`, retrieved 2026-10-26)
- Primary completion: 2022-02-09 (actual) (ClinicalTrials.gov record NCT05053243, source copy `cardio:ctgov-nct05053243-2024-03-06`, retrieved 2026-10-26)
- Completion: 2023-05-24 (actual) (ClinicalTrials.gov record NCT05053243, source copy `cardio:ctgov-nct05053243-2024-03-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05053243, source copy `cardio:ctgov-nct05053243-2024-03-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05053243-2024-03-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Validation of the AliveCor Kardia 12L and 6L Devices
- Condition: Arrhythmia
- Intervention (Device): Kardia 12L
- Lead sponsor: University of Oklahoma
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: University of Oklahoma (`cardio:org-university-of-oklahoma`)

## Provenance

Content hash: 3a1ffa39ae05f54e34c3d0310a81902feef7ffc4cc4cff1492e3809a3f1957f0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
